Are placebo controls necessary in controlled human infection trials for vaccines?

The Lancet Infectious Diseases
Marijke C C LangenbergMeta Roestenberg

Abstract

Controlled human infection trials, whereby a small group of healthy participants is deliberately exposed to a pathogen under controlled circumstances, can provide preliminary data for vaccine efficacy and for the selection of the most promising candidate vaccines for field trials. Because of the potential harm to participants through the deliberate exposure to a pathogen, the use of smaller groups minimises the cumulative risk. As such, a control group that receives a placebo vaccine followed by controlled exposure to a pathogen should be scientifically well justified. As these types of trials are designed to generate consistent infection rates and thus comparable outcomes across populations and trial sites, data from past studies (historical data) could be used as a valid alternative to placebo groups. In this Personal View, we review this option and highlight the considerations for choosing historical data as a suitable control. For the widespread application of this method, responsibility for the centralisation and sharing of data from controlled human infection trials lies with the scientific community.

References

May 1, 1994·Antimicrobial Agents and Chemotherapy·F G HaydenJ Harris
Aug 31, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·F G Miller, C Grady
Feb 12, 2004·Journal of Medical Ethics·T Hope, J McMillan
Feb 17, 2005·JAMA : the Journal of the American Medical Association·Bernhard J HeringDavid E R Sutherland
Feb 17, 2007·BMJ : British Medical Journal·Paul GlasziouPeter McCulloch
Apr 23, 2008·Archives of Disease in Childhood. Fetal and Neonatal Edition·P M Dunn
May 13, 2009·The Journal of Infectious Diseases·Diane M JanowiczStanley M Spinola
Dec 5, 2009·Malaria Journal·An-Emmie NiemanAndré van der Ven
Dec 24, 2010·Nature Reviews. Immunology·Robert W SauerweinVasee S Moorthy
Jul 26, 2011·Trends in Microbiology·Daniela M FerreiraStephen B Gordon
Aug 5, 2011·The American Journal of Tropical Medicine and Hygiene·Cynthia L ChappellSaul Tzipori
Aug 6, 2013·Pharmaceutical Statistics·Kert VieleLaura Thompson
Oct 12, 2013·Malaria Journal·Geoffrey A T TargettGraham V Brown
Feb 1, 2014·Malaria Journal·Maurits P A van MeerRobert W Sauerwein
Feb 13, 2014·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Claire S WaddingtonAndrew J Pollard
Oct 15, 2014·The American Journal of Tropical Medicine and Hygiene·Cynthia L ChappellSaul Tzipori
Sep 30, 2015·The American Journal of Tropical Medicine and Hygiene·Kirsten E LykeStephen L Hoffman
Oct 2, 2015·Vaccine·Christian P LarsenAnna P Durbin
May 22, 2016·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Shobana Balasingam, Annelies Wilder-Smith
Sep 18, 2016·Clinics in Dermatology·Andrzej GrzybowskiJakub Pawlikowski
Nov 28, 2016·Vaccine·Maximillian S Habibi, Christopher Chiu
Jan 18, 2017·JCI Insight·Judith E EpsteinStephen L Hoffman
Jun 24, 2017·Science Translational Medicine·Matthew B B McCallRobert W Sauerwein
Dec 21, 2017·The American Journal of Tropical Medicine and Hygiene·Bertrand LellPeter G Kremsner
Apr 1, 2016·Public Health Ethics·Ben BamberyAndrew J Pollard
May 22, 2018·Open Forum Infectious Diseases·David DiemertJeffrey M Bethony
Jun 16, 2018·The Journal of Infectious Diseases·Jacqueline J JanseMeta Roestenberg
Jul 18, 2018·The American Journal of Tropical Medicine and Hygiene·Marijke C C LangenbergRobert W Sauerwein
Sep 27, 2018·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Malick M GibaniAndrew J Pollard
May 12, 2019·The Journal of Infectious Diseases·Marie-Astrid HoogerwerfMeta Roestenberg
Jul 2, 2019·Clinical Trials : Journal of the Society for Clinical Trials·David Alan SchoenfeldUNKNOWN Pooled Resource Open-Access ALS Clinical Trials Consortium

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.